Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia
Condition(s):SchizophreniaLast Updated:December 9, 2019Completed
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:December 9, 2019Completed
Condition(s):Traumatic Brain InjuryLast Updated:December 12, 2014Completed
Condition(s):HealthyLast Updated:January 7, 2021Completed
Condition(s):Septic ShockLast Updated:February 4, 2014Completed
Condition(s):Portal Blood Pressure; Liver Surgery; Hepatic HemodynamicsLast Updated:November 8, 2018Completed
Condition(s):Pleural Effusion; Single-ventricleLast Updated:December 13, 2022Withdrawn
Condition(s):MyomaLast Updated:May 13, 2019Unknown status
Condition(s):Blood Loss During Vaginal HysterectomyLast Updated:July 24, 2018Completed
Condition(s):Colon Cancer Liver Metastasis; Inflammatory Response; Vasopressin Causing Adverse Effects in Therapeutic UseLast Updated:July 13, 2023Recruiting
Condition(s):Shock, SepticLast Updated:November 29, 2017Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.